CD274 and breast carcinoma: Moreover, some evidence suggests that taxanes may promote expression of PD-L1 by human breast cancer cells [88], which may then act to enhance the antitumor effect of a PD-L1 immune checkpoint inhibitor, as reported for metastatic TNBC patients [62].